Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition revenue climbs despite swing to annual loss

Wed, 03rd May 2023 17:21

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it had a "transformative" 2022, as revenue climbed 25% against the previous year.

The Cambridge, England-based digital health products technology developer said revenue in 2022 rose to GBP12.6 million, up 25% from GBP10.1 million a year earlier. Services revenue grew by 16% in 2022 to GBP6.5 million, whilst Software revenue climbed 39% to GBP5.0 million.

However, the company swung to a pretax loss of GBP600,000 from a pretax profit of GBP300,000 year-on-year. It also swung to a loss per share of 1.3 pence, from an earnings per share of 1.4 pence.

The financial results for the year were tempered by a slightly slower-than-expected final quarter, as the company experienced delays and scope reduction associated with large orders, Cambridge Cognition explained. It added that market forecasts suggest that this is not representative of a long-term trend.

The company ended 2022 with a contracted order book of GBP17.6 million, which increased further to GBP19.1 million in January, following the acquisition of Winterlight Labs.

Cambridge Cognition bought Winterlight Labs for GBP7.0 million back in January.

Looking ahead, Cambridge Cognition said that its strong contracted order book provides "excellent" revenue visibility through 2023.

"2022 was a transformational year for Cambridge Cognition, marked by significant multi-year orders, sustained revenue growth, and the expansion of our core product set," said Chief Executive Officer Matthew Stork.

"Looking ahead, we remain committed to our objectives of driving revenue and profit growth by increasing our market share through offering the most innovative technology, supported by outstanding scientific evidence and a very experienced team, in the high-value market for CNS drug development."

Shares in Cambridge Cognition closed down 4.6% to 93.00 pence each.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Apr 2021 11:24

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

Read more
30 Mar 2021 16:03

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

Read more
30 Mar 2021 13:56

Cambridge Cognition wins fourth schizophrenia trial contract

(Sharecast News) - Cambridge Cognition has won a £1.3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.

Read more
23 Mar 2021 11:58

Cambridge Cognition shares surge as it eyes profitability in 2021

Cambridge Cognition shares surge as it eyes profitability in 2021

Read more
16 Mar 2021 15:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Jan 2021 13:45

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Read more
21 Dec 2020 14:20

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more
22 Sep 2020 14:12

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

Read more
15 Sep 2020 15:53

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
1 Sep 2020 16:22

Cambridge Cognition wins £2m contract with pharma firm

(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.

Read more
1 Sep 2020 11:57

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Read more
27 Jul 2020 17:58

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

Read more
20 Jul 2020 15:53

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.